Evidence map›Paper›PMID 33909991›Full record

ArticleAmerican journal of human genetics2021

EPISPOT: An epigenome-driven approach for detecting and interpreting hotspots in molecular QTL studies.

Hélène Ruffieux, Benjamin P Fairfax, Isar Nassiri, Elena Vigorito, Chris Wallace, Sylvia Richardson, Leonardo Bottolo

Open access · hybridAbstract read
In one paragraph

Article in American journal of human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Multimodal analysis methods in predictive biomedicine.Computational and structural biotechnology journal · 2023
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hélène RuffieuxMRC Biostatistics Unit, University of Cambridge, Cambridge CB2 0SR, UK. Electronic address: helene.ruffieux@mrc-bsu.cam.ac.uk.
Benjamin P FairfaxDepartment of Oncology, MRC Weatherall Institute for Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.
Isar NassiriDepartment of Oncology, MRC Weatherall Institute for Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.
Elena VigoritoMRC Biostatistics Unit, University of Cambridge, Cambridge CB2 0SR, UK.
Chris WallaceMRC Biostatistics Unit, University of Cambridge, Cambridge CB2 0SR, UK; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0AW, UK.
Sylvia RichardsonMRC Biostatistics Unit, University of Cambridge, Cambridge CB2 0SR, UK; The Alan Turing Institute, London NW1 2DB, UK.
Leonardo BottoloMRC Biostatistics Unit, University of Cambridge, Cambridge CB2 0SR, UK; The Alan Turing Institute, London NW1 2DB, UK; Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK.
University of Cambridge · GBJohn Radcliffe Hospital · GBTuring Institute · GB

Funding

Medical Research Council MC UU 00002/4Medical Research Council MC_UU_00002/4Medical Research Council MRC MC UU 00002/10Medical Research Council MR M0 13138/1Medical Research Council MR S0 2638X/1Wellcome TrustWellcome Trust 201488/Z/16/ZWellcome Trust WT107881
6 · The paper itself

Abstract

We present EPISPOT, a fully joint framework which exploits large panels of epigenetic annotations as variant-level information to enhance molecular quantitative trait locus (QTL) mapping. Thanks to a purpose-built Bayesian inferential algorithm, EPISPOT accommodates functional information for both cis and trans actions, including QTL hotspot effects. It effectively couples simultaneous QTL analysis of thousands of genetic variants and molecular traits with hypothesis-free selection of biologically interpretable annotations which directly contribute to the QTL effects. This unified, epigenome-aided learning boosts statistical power and sheds light on the regulatory basis of the uncovered hits; EPISPOT therefore marks an essential step toward improving the challenging detection and functional interpretation of trans-acting genetic variants and hotspots. We illustrate the advantages of EPISPOT in simulations emulating real-data conditions and in a monocyte expression QTL study, which confirms known hotspots and finds other signals, as well as plausible mechanisms of action. In particular, by highlighting the role of monocyte DNase-I sensitivity sites from >150 epigenetic annotations, we clarify the mediation effects and cell-type specificity of major hotspots close to the lysozyme gene. Our approach forgoes the daunting and underpowered task of one-annotation-at-a-time enrichment analyses for prioritizing cis and trans QTL hits and is tailored to any transcriptomic, proteomic, or metabolomic QTL problem. By enabling principled epigenome-driven QTL mapping transcriptome-wide, EPISPOT helps progress toward a better functional understanding of genetic regulation.

Indexed as

AlgorithmsComputer SimulationEpigenomeModels, GeneticMutationPhenotypeQuantitative Trait LociBayes TheoremChromosome MappingHumansepigenetic annotationshierarchical modellinglarge-scale multivariate mappingmolecular QTL studiestrans hotspotsvariational EM algorithm

Identifiers

PMID33909991
PMCPMC8206410
OpenAlexW3157947804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.